[1]
P. T, M. PT, and A. E, “IN SILICO DESIGN OF QUINOXALINE BEARING THIAZOLIDINONE DERIVATIVES AS PPARγ AGONIST IN DIABETES MELLITUS”, Asian J Pharm Clin Res, vol. 14, no. 2, pp. 47–50, Feb. 2021.